Mechanism
SGLT2;DPP-4
Assets acting on this target.
- Class
- SGLT2 inhibitor + DPP-4 inhibitor fixed-dose combination
- Notes
- audit finding #2221 (minor); source: https://clinicaltrials.gov/api/v2/studies/NCT04972539
Mechanism
Assets acting on this target.
1 of 1 assets